Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Hemorrhage | 12 | 2021 | 98 | 1.880 |
Why?
|
| Subarachnoid Hemorrhage | 9 | 2021 | 39 | 1.080 |
Why?
|
| Brain Diseases | 1 | 2021 | 60 | 0.690 |
Why?
|
| Fever | 1 | 2017 | 33 | 0.520 |
Why?
|
| Hospital Mortality | 7 | 2021 | 127 | 0.470 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 6 | 2021 | 87 | 0.390 |
Why?
|
| Time Factors | 11 | 2020 | 1376 | 0.370 |
Why?
|
| Drainage | 3 | 2021 | 44 | 0.330 |
Why?
|
| Brain Ischemia | 2 | 2021 | 61 | 0.330 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2019 | 111 | 0.320 |
Why?
|
| Female | 22 | 2021 | 14543 | 0.310 |
Why?
|
| Humans | 31 | 2021 | 25900 | 0.310 |
Why?
|
| Severity of Illness Index | 4 | 2017 | 830 | 0.310 |
Why?
|
| Nervous System Diseases | 2 | 2020 | 118 | 0.280 |
Why?
|
| Cerebral Infarction | 2 | 2021 | 147 | 0.280 |
Why?
|
| Middle Aged | 17 | 2021 | 8556 | 0.270 |
Why?
|
| Brain Edema | 2 | 2020 | 13 | 0.270 |
Why?
|
| Male | 22 | 2021 | 14176 | 0.270 |
Why?
|
| Encephalocele | 2 | 2020 | 24 | 0.270 |
Why?
|
| Retrospective Studies | 11 | 2021 | 3342 | 0.270 |
Why?
|
| Risk Factors | 8 | 2021 | 2173 | 0.260 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 2 | 2019 | 8 | 0.260 |
Why?
|
| Emergency Medical Services | 2 | 2020 | 32 | 0.260 |
Why?
|
| Prospective Studies | 9 | 2021 | 1686 | 0.250 |
Why?
|
| Fibrinolytic Agents | 3 | 2017 | 57 | 0.250 |
Why?
|
| Stroke | 3 | 2017 | 262 | 0.240 |
Why?
|
| Critical Care | 3 | 2020 | 118 | 0.230 |
Why?
|
| Hydrocephalus | 2 | 2021 | 16 | 0.220 |
Why?
|
| Risk Assessment | 4 | 2021 | 553 | 0.210 |
Why?
|
| Intracranial Thrombosis | 2 | 2020 | 6 | 0.200 |
Why?
|
| Weather | 2 | 2019 | 13 | 0.190 |
Why?
|
| Length of Stay | 3 | 2021 | 307 | 0.190 |
Why?
|
| Pandemics | 2 | 2020 | 221 | 0.180 |
Why?
|
| Aged | 14 | 2021 | 8658 | 0.180 |
Why?
|
| Hospitalization | 2 | 2020 | 295 | 0.180 |
Why?
|
| Leukocytosis | 1 | 2021 | 5 | 0.180 |
Why?
|
| Cerebrum | 1 | 2021 | 9 | 0.170 |
Why?
|
| Brain Death | 1 | 2020 | 8 | 0.170 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 7 | 0.170 |
Why?
|
| Occupational Health | 1 | 2020 | 16 | 0.170 |
Why?
|
| Neurologists | 1 | 2020 | 4 | 0.170 |
Why?
|
| Prognosis | 3 | 2020 | 695 | 0.170 |
Why?
|
| Hyperglycemia | 1 | 2020 | 27 | 0.170 |
Why?
|
| Health Care Rationing | 1 | 2020 | 5 | 0.170 |
Why?
|
| Apnea | 1 | 2020 | 16 | 0.170 |
Why?
|
| Logistic Models | 3 | 2017 | 368 | 0.170 |
Why?
|
| Cerebral Angiography | 3 | 2021 | 31 | 0.170 |
Why?
|
| Pregnancy | 1 | 2021 | 327 | 0.170 |
Why?
|
| Rivaroxaban | 1 | 2020 | 5 | 0.170 |
Why?
|
| Hematoma, Subdural | 1 | 2020 | 6 | 0.170 |
Why?
|
| Hemostasis | 1 | 2020 | 9 | 0.170 |
Why?
|
| Pyridones | 1 | 2020 | 10 | 0.170 |
Why?
|
| Factor Xa Inhibitors | 1 | 2020 | 4 | 0.170 |
Why?
|
| Hemostatics | 1 | 2020 | 11 | 0.170 |
Why?
|
| Blood Glucose | 1 | 2020 | 99 | 0.170 |
Why?
|
| Blood Coagulation Factors | 1 | 2020 | 20 | 0.160 |
Why?
|
| Electroencephalography | 1 | 2020 | 83 | 0.160 |
Why?
|
| Seizures | 1 | 2020 | 70 | 0.160 |
Why?
|
| Pyrazoles | 1 | 2020 | 32 | 0.160 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 66 | 0.160 |
Why?
|
| Neurology | 1 | 2020 | 37 | 0.160 |
Why?
|
| Endocarditis | 1 | 2019 | 7 | 0.160 |
Why?
|
| Vasospasm, Intracranial | 1 | 2019 | 10 | 0.160 |
Why?
|
| Brain Injuries | 1 | 2019 | 24 | 0.160 |
Why?
|
| Disease Management | 1 | 2019 | 91 | 0.150 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 162 | 0.150 |
Why?
|
| Delirium | 1 | 2018 | 12 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 78 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 82 | 0.150 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 309 | 0.150 |
Why?
|
| Cerebral Ventricles | 1 | 2017 | 17 | 0.140 |
Why?
|
| Critical Illness | 1 | 2018 | 113 | 0.140 |
Why?
|
| Cerebral Intraventricular Hemorrhage | 1 | 2017 | 2 | 0.130 |
Why?
|
| Body Temperature Regulation | 1 | 2017 | 19 | 0.130 |
Why?
|
| Therapeutic Irrigation | 1 | 2017 | 56 | 0.130 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 127 | 0.130 |
Why?
|
| Adult | 9 | 2021 | 7517 | 0.130 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2017 | 43 | 0.130 |
Why?
|
| Sodium Chloride | 1 | 2017 | 34 | 0.130 |
Why?
|
| Odds Ratio | 1 | 2017 | 254 | 0.130 |
Why?
|
| Cytokines | 1 | 2017 | 231 | 0.120 |
Why?
|
| Chicago | 4 | 2020 | 906 | 0.110 |
Why?
|
| Troponin I | 1 | 2013 | 8 | 0.100 |
Why?
|
| Intracranial Hypertension | 1 | 2013 | 13 | 0.100 |
Why?
|
| Treatment Outcome | 5 | 2021 | 3339 | 0.100 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 4633 | 0.100 |
Why?
|
| Community Health Centers | 1 | 2012 | 11 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 421 | 0.100 |
Why?
|
| Warfarin | 1 | 2012 | 25 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 631 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2012 | 81 | 0.090 |
Why?
|
| Injections, Intra-Arterial | 1 | 2011 | 5 | 0.090 |
Why?
|
| Transportation of Patients | 1 | 2011 | 4 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 1071 | 0.090 |
Why?
|
| Thrombolytic Therapy | 1 | 2011 | 48 | 0.090 |
Why?
|
| Perfusion Imaging | 1 | 2010 | 6 | 0.090 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2010 | 11 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 1 | 2010 | 29 | 0.080 |
Why?
|
| Ischemic Attack, Transient | 1 | 2010 | 18 | 0.080 |
Why?
|
| Young Adult | 4 | 2019 | 1929 | 0.080 |
Why?
|
| Leukocyte Count | 2 | 2021 | 61 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 261 | 0.080 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 235 | 0.080 |
Why?
|
| Patient Discharge | 2 | 2021 | 147 | 0.080 |
Why?
|
| Atmospheric Pressure | 2 | 2019 | 8 | 0.080 |
Why?
|
| Brain Infarction | 1 | 2009 | 75 | 0.080 |
Why?
|
| Intensive Care Units | 2 | 2020 | 261 | 0.070 |
Why?
|
| Age Factors | 2 | 2020 | 738 | 0.070 |
Why?
|
| Incidence | 2 | 2019 | 720 | 0.060 |
Why?
|
| Biomarkers | 2 | 2020 | 536 | 0.060 |
Why?
|
| Recovery of Function | 2 | 2020 | 296 | 0.060 |
Why?
|
| United States | 2 | 2020 | 1935 | 0.060 |
Why?
|
| Hypertension | 2 | 2018 | 176 | 0.060 |
Why?
|
| Brain | 2 | 2021 | 1604 | 0.050 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2021 | 8 | 0.050 |
Why?
|
| Weaning | 1 | 2021 | 6 | 0.050 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2021 | 26 | 0.040 |
Why?
|
| Patient Admission | 1 | 2021 | 23 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 52 | 0.040 |
Why?
|
| Registries | 2 | 2012 | 184 | 0.040 |
Why?
|
| Critical Care Nursing | 1 | 2020 | 3 | 0.040 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2020 | 15 | 0.040 |
Why?
|
| Pharmacists | 1 | 2020 | 17 | 0.040 |
Why?
|
| Triage | 1 | 2020 | 19 | 0.040 |
Why?
|
| Patient Transfer | 1 | 2020 | 25 | 0.040 |
Why?
|
| Physician Assistants | 1 | 2020 | 10 | 0.040 |
Why?
|
| Self Concept | 1 | 2020 | 38 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 41 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 107 | 0.040 |
Why?
|
| Nurse Practitioners | 1 | 2020 | 35 | 0.040 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2019 | 7 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 2019 | 14 | 0.040 |
Why?
|
| Nurses | 1 | 2020 | 44 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 23 | 0.040 |
Why?
|
| Syndrome | 1 | 2019 | 69 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 125 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 61 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 67 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2021 | 257 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 450 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 140 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 290 | 0.040 |
Why?
|
| Temperature | 1 | 2018 | 54 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 457 | 0.040 |
Why?
|
| Physicians | 1 | 2020 | 113 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2020 | 203 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 328 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2020 | 201 | 0.040 |
Why?
|
| Sex Factors | 1 | 2019 | 453 | 0.040 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2017 | 8 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2017 | 18 | 0.030 |
Why?
|
| Leukocytes | 1 | 2017 | 34 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 619 | 0.030 |
Why?
|
| Glucose | 1 | 2017 | 54 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1324 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 313 | 0.030 |
Why?
|
| Factor VIIa | 1 | 2012 | 7 | 0.020 |
Why?
|
| Plasma | 1 | 2012 | 15 | 0.020 |
Why?
|
| International Normalized Ratio | 1 | 2012 | 19 | 0.020 |
Why?
|
| Smoking | 1 | 2012 | 173 | 0.020 |
Why?
|
| Middle Cerebral Artery | 1 | 2010 | 6 | 0.020 |
Why?
|
| Carotid Artery, Internal | 1 | 2010 | 6 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 431 | 0.020 |
Why?
|